Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:03 pm Sale | 2021-12-31 | 13G | Ambrx Biopharma Inc. AMAM | HBM Healthcare Investments (Cayman) Ltd. | 16,856,567 6.900% | -898,156 (-5.06%) | Filing History |
| 2022-02-11 4:02 pm Purchase | 2021-12-31 | 13G | IO Biotech, Inc. IOBT | HBM Healthcare Investments (Cayman) Ltd. | 2,420,484 8.400% | 2,420,484 (New Position) | Filing History |
| 2022-02-11 4:02 pm Sale | 2021-12-31 | 13G | Galecto, Inc. GLTO | HBM Healthcare Investments (Cayman) Ltd. | 0 0.000% | -52,297 (Position Closed) | Filing History |
| 2022-02-11 4:00 pm Sale | 2021-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | HBM Healthcare Investments (Cayman) Ltd. | 4,545,243 7.800% | -96,536 (-2.08%) | Filing History |
| 2022-02-07 5:13 pm Purchase | 2021-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | HBM Healthcare Investments (Cayman) Ltd. | 3,090,954 7.100% | 960,581 (+45.09%) | Filing History |
| 2021-07-02 4:00 pm Purchase | 2021-06-22 | 13G | Ambrx Biopharma Inc. AMAM | HBM Healthcare Investments (Cayman) Ltd. | 17,754,723 6.700% | 17,754,723 (New Position) | Filing History |
| 2021-03-22 4:23 pm Purchase | 2021-03-12 | 13G | Longboard Pharmaceuticals, Inc. LBPH | HBM Healthcare Investments (Cayman) Ltd. | 1,327,430 9.990% | 1,327,430 (New Position) | Filing History |
| 2021-02-12 4:00 pm Purchase | 2020-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | HBM Healthcare Investments (Cayman) Ltd. | 4,641,779 8.200% | 4,641,779 (New Position) | Filing History |
| 2021-02-12 4:00 pm Sale | 2020-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | HBM Healthcare Investments (Cayman) Ltd. | 2,130,373 5.300% | -657,452 (-23.58%) | Filing History |
| 2021-02-12 4:00 pm Purchase | 2020-12-31 | 13G | Galecto, Inc. GLTO | HBM Healthcare Investments (Cayman) Ltd. | 52,297 5.200% | 52,297 (New Position) | Filing History |
| 2020-12-28 4:06 pm Purchase | 2020-12-15 | 13G | BioAtla, Inc. BCAB | HBM Healthcare Investments (Cayman) Ltd. | 2,690,869 8.800% | 2,690,869 (New Position) | Filing History |